Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells

International Journal of Cancer

Volumn 86, Issue 2, 2000, Pages 182-187

  Eberl, Lucie Peduto ^a   Valdenaire, Olivier ^b   Saintgiorgio, Valérie ^c   Jeannin, Jean François ^c   Juillerat Jeanneret, Lucienne ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b INSERM   (France)

^c PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CASPASE INHIBITOR; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLON CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; ENZYME INHIBITION; ENZYME SPECIFICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BLOCKING;

EID: 0034126340     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000415)86:2<182::AID-IJC6>3.0.CO;2-G     Document Type: Article

References (20)

1. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. and NAKANISHI, S., Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.), 348, 730-732 (1990).
2. B receptors in anaesthetised rats. Int. J. Cancer, 73, 283-289, (1997).
3. CLOZEL, M., BREU, V., BURRI, K., CASSAL, J.M., FISCHLI, W., GRAY, G.A., HIRTH, G., LOFFLER, B.M., MULLER, M., NEIDHART, W. and RAMUZ, H., Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature (Lond), 365, 759-761 (1993).
4. CORONEOS, E., MARTINEZ, M., MCKENNA, S. and KESTER, M., Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J. biol. Chem., 270, 23305-23309 (1995).
5. JEANNIN, J.F., ONIER, N., LAGADEC, P., JENEY, N., STÜTZ, P. and LIEHL, E., Antitumor effect of synthetic derivatives of lipid A in an experimental model of colon cancer in the rat. Gastroenterology, 101, 726-734, (1991).
6. KUSUHARA, M., YAMAGUCHI, K., NAGASAKI, K., HAYASHI, C., SUZAKI, A., HORI, S., HANDA, S., NAKAMURA, Y. and ABE, K., Production of endothelin in human cancer cell lines. Cancer Res., 50, 3257-3261 (1990).
7. NAGATA, S. and GOLDSTEIN, P., The Fas death receptor. Science, 267, 1449-1456 (1995).
8. NELSON, J.B., CHAN-TACK, K., HEDICAN, S.P., MAGNUSON, S.R., OPGENORTH, T.J., BOVA, J.S. and SIMONS, J.W., Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res., 56, 663-668 (1996).
9. O'CONNELL, J.O., BENNETT, M.W., O'SULLIVAN, G.C., ROCHE, D., KELLY, J., COLLINS, J.K. and SHANAHAN, F., Fas Ligand expression in primary colon adenocarcinomas : evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. J. Pathol., 186, 240-246 (1998).
10. PEDUTO EBERL, L., GUILLOU, L., SARAGA, E., SCHRÖTER, M., FRENCH, L.E., TSCHOPP, J. and JUILLERAT-JEANNERET, L., Fas and Fas ligand expression in tumor cells and in vascular smooth muscle cells of colon and renal carcinomas. Int. J. Cancer, 81, 772-778 (1999).
11. RENSING-EHL, A., FREI, K., FLURY, R., MATIBA, B., MARIANI, S.M., WELLER, M., AEBISCHER, P., KRAMMER, P.H. and FONTANA, A., Locoregional Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Europ. J. Immunol., 25, 2253-2258 (1995).
12. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. and MASAKI, T., Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (Lond.), 348, 732-735 (1990).
13. SHANKAR, A., LOIZIDOU, M., ALIEV, G., FREDERICKS, S., HOLT, D., BOULOS, P.B., BURNSTOCK, G. and TAYLOR, I., Raised endothelin-1 levels in patients with colorectal liver metastases. Brit. J. Surg., 85, 502-506 (1998).
14. SHICHIRI, M., HIRATA, Y., NAKAJIMA, T., ANDO, K., IMAI, T., YANAGISAWA, M., MASAKI, T. and MARUMO, F., Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J. clin. Invest., 87, 1867-1871 (1991).
15. SHICHIRI, M., KATO, H., MARUMO, F. and HIRATA, Y., Endothelin-1 as an autocrine/paracrine survival factor for endothelial cells. Hypertension, 30, 1198-1203 (1997).
16. SHICHIRI, M., SEDIVY, J.M., MARUMO, F. and HIRATA, Y., Endothelin-1 is a potent survival factor for c-myc-dependent apoptosis. Mol. Endocrinol., 12, 172-180 (1998).
17. SHIMADA, K., MATSUSHITA, Y., WAKABAYASHI, K., TAKAHASHI, M., MATSUBA, A., IUIMA, Y. and TANZAWA, K., Cloning and functional expression of human converting enzyme cDNA. Biochem. biophys. Res. Comm., 207, 807-812 (1995).
18. SPIEGEL, S. and MERRILL, A.H., Sphingolipid metabolism and cell growth regulation. FASEB J., 10, 1388-1397 (1996).
19. THORNBERRY, N.A. and LAZEBNIK, Y., Caspases : enemies within. Science, 281, 1312-1316 (1998).
20. WU-WONG, J., CHIOU, W.J., DICKINSON, R. and OPGENORTH, T.J., Endothelin attenuates apoptosis in human smooth muscle cells. Biochem. J., 328, 733-737 (1997).